Download Citation
Article Source:
Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial
Ikeda HO,
Muraoka Y,
Hata M,
Sumi E,
Ikeda T,
et al.
(2020)
Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial.
PLOS ONE 15(2): e0229068.
https://doi.org/10.1371/journal.pone.0229068